Travere Therapeutics, Inc. (NASDAQ:TVTX) Q2 2025 Earnings Call Transcript August 6, 2025
Travere Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.14, expectations were $-0.28.
Operator: Good afternoon, and welcome to the Travere Therapeutics Second Quarter 2025 Financial Results Conference Call. Today’s call is being recorded. At this time, I would like to turn the conference over to Nevi Nehra, Vice President, Corporate Communications and Investor Relations.
Nivi Nehra:...
